SG11201601646YA - Deoxynojirimycin derivatives and methods of their using - Google Patents
Deoxynojirimycin derivatives and methods of their usingInfo
- Publication number
- SG11201601646YA SG11201601646YA SG11201601646YA SG11201601646YA SG11201601646YA SG 11201601646Y A SG11201601646Y A SG 11201601646YA SG 11201601646Y A SG11201601646Y A SG 11201601646YA SG 11201601646Y A SG11201601646Y A SG 11201601646YA SG 11201601646Y A SG11201601646Y A SG 11201601646YA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- deoxynojirimycin derivatives
- deoxynojirimycin
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361878286P | 2013-09-16 | 2013-09-16 | |
| PCT/US2014/055599 WO2015039010A2 (en) | 2013-09-16 | 2014-09-15 | Deoxynojirimycin derivatives and methods of their using |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201601646YA true SG11201601646YA (en) | 2016-04-28 |
Family
ID=52666528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201601646YA SG11201601646YA (en) | 2013-09-16 | 2014-09-15 | Deoxynojirimycin derivatives and methods of their using |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10144727B2 (ru) |
| EP (1) | EP3046558B1 (ru) |
| JP (1) | JP6456393B2 (ru) |
| KR (1) | KR20160055916A (ru) |
| CN (1) | CN105636589B (ru) |
| AP (1) | AP2016009125A0 (ru) |
| AU (1) | AU2014318488B2 (ru) |
| BR (1) | BR112016005417A8 (ru) |
| CA (1) | CA2924026C (ru) |
| CL (1) | CL2016000597A1 (ru) |
| CR (1) | CR20160178A (ru) |
| HK (1) | HK1222129A1 (ru) |
| IL (1) | IL244446A0 (ru) |
| MX (1) | MX2016003323A (ru) |
| PH (1) | PH12016500465A1 (ru) |
| RU (1) | RU2702133C2 (ru) |
| SG (1) | SG11201601646YA (ru) |
| WO (1) | WO2015039010A2 (ru) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9682914B2 (en) | 2014-01-13 | 2017-06-20 | P2 Science, Inc. | Terpene-derived acids and esters and methods for preparing and using same |
| US10071944B2 (en) | 2014-06-20 | 2018-09-11 | P2 Science, Inc. | Film ozonolysis in a tubular or multitubular reactor |
| WO2016022803A2 (en) * | 2014-08-06 | 2016-02-11 | P2 Science, Inc. | Fragrances from the esters of fatty acids |
| JP6826986B2 (ja) | 2014-11-05 | 2021-02-10 | エマージェント バイロロジー エルエルシー | ウィルス性疾患の治療に有用なイミノ糖類 |
| WO2017201052A1 (en) * | 2016-05-16 | 2017-11-23 | Emergent Virology Llc | Methods of treating zika virus infection |
| WO2017201030A1 (en) * | 2016-05-16 | 2017-11-23 | Emergent Virology Llc | Methods of treating viral infection |
| JP7028457B2 (ja) | 2016-06-21 | 2022-03-02 | ピー２・サイエンス・インコーポレイテッド | 過酸化物混合物の連続クエンチのためのフロースルー反応器およびそれを含む方法 |
| WO2018053289A1 (en) | 2016-09-16 | 2018-03-22 | P2 Science, Inc. | Uses of vanadium to oxidize aldehydes and ozonides |
| CN111904959A (zh) * | 2020-08-21 | 2020-11-10 | 牡丹江医学院 | α-L-岩藻糖苷酶抑制剂在制备治疗小儿肺炎的药物中的用途 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2758025A1 (de) * | 1977-12-24 | 1979-07-12 | Bayer Ag | Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung |
| DE2834122A1 (de) | 1978-08-03 | 1980-02-14 | Bayer Ag | Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose |
| DE2853573A1 (de) | 1978-12-12 | 1980-07-03 | Bayer Ag | Herstellung von n-substituierten derivaten des l-desoxynojirimycins |
| DE3007078A1 (de) * | 1980-02-26 | 1981-09-10 | Bayer Ag, 5090 Leverkusen | Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung |
| DE3038901A1 (de) | 1980-10-15 | 1982-05-06 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins |
| DE3611841A1 (de) | 1986-04-09 | 1987-10-15 | Bayer Ag | Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten |
| US5043273A (en) | 1989-08-17 | 1991-08-27 | Monsanto Company | Phosphorylated glycosidase inhibitor prodrugs |
| US5103008A (en) | 1989-08-17 | 1992-04-07 | Monsanto Company | Compound, N-butyl-deoxynojirimycin-6-phosphate |
| US4994572A (en) | 1989-10-12 | 1991-02-19 | Monsanto Company | Synthesis of nojirimycin derivatives |
| US5200523A (en) | 1990-10-10 | 1993-04-06 | Monsanto Company | Synthesis of nojirimycin derivatives |
| WO1995022975A1 (en) | 1994-02-25 | 1995-08-31 | G.D. Searle & Co. | Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus |
| US20030100532A1 (en) | 1997-02-14 | 2003-05-29 | Gary S. Jacob | Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
| US6465487B1 (en) | 1997-12-11 | 2002-10-15 | Synergy Pharmaceuticals, Inc. | Inhibition of membrane-associated viral replication |
| US6689759B1 (en) | 1998-02-12 | 2004-02-10 | G. D. Searle & Co. | Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy |
| GB9828474D0 (en) | 1998-12-24 | 1999-02-17 | British Aerospace | Surface topology inspection |
| US6545021B1 (en) | 1999-02-12 | 2003-04-08 | G.D. Searle & Co. | Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections |
| US7256005B2 (en) | 1999-08-10 | 2007-08-14 | The Chancellor, Masters And Scholars Of The University Of Oxford | Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity |
| WO2001010429A2 (en) | 1999-08-10 | 2001-02-15 | The Chancellor, Masters, And Scholars Of The University Of Oxford | Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
| US7427758B2 (en) | 2003-05-28 | 2008-09-23 | Opto-Knowledge Systems, Inc. | Cryogenically cooled adjustable apertures for infra-red cameras |
| FR2861991B1 (fr) * | 2003-11-07 | 2008-01-18 | Centre Nat Rech Scient | Utilisation d'inhibiteurs de glucosidase pour une therapie de la mucoviscidose |
| EP2023927B1 (en) | 2006-05-24 | 2015-02-25 | United Therapeutics Corporation | Deoxynojirimycin and d-arabinitol analogs and methods of using |
| JP2009545621A (ja) | 2006-08-02 | 2009-12-24 | ユナイテッド セラピューティクス コーポレーション | ウィルス感染症のリポソーム処置 |
| US8097728B2 (en) * | 2007-04-30 | 2012-01-17 | Philadelphia Health & Education Corporation | Iminosugar compounds with antiflavirus activity |
| KR20100127842A (ko) | 2008-03-26 | 2010-12-06 | 유니버시티 오브 옥스퍼드 | 소포체 표적화 리포좀 |
| WO2010027996A1 (en) * | 2008-09-02 | 2010-03-11 | Institute For Hepatitis And Virus Research | Novel imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity |
| KR20120042716A (ko) * | 2009-02-23 | 2012-05-03 | 유나이티드 세러퓨틱스 코오포레이션 | 이미노슈가 및 바이러스성 질환을 치료하는 방법 |
| ES2562635T3 (es) | 2009-02-24 | 2016-03-07 | United Therapeutics Corporation | Iminoazúcares y métodos de tratamiento de infecciones producidas por arenavirus |
| EP2410989A2 (en) | 2009-03-27 | 2012-02-01 | The Chancellor, Masters and Scholars of the University of Oxford | Cholesterol level lowering liposomes |
| CA2765086C (en) | 2009-06-12 | 2015-12-15 | United Therapeutics Corporation | Iminosugars and methods of treating bunyaviral and togaviral diseases |
| CN102625801B (zh) | 2009-09-04 | 2015-09-09 | 联合治疗公司 | 治疗痘病毒感染的方法 |
| US20110065754A1 (en) | 2009-09-04 | 2011-03-17 | United Therapeutics Corporation | Iminosugars and methods of treating filoviral diseases |
| JP5653438B2 (ja) * | 2009-09-04 | 2015-01-14 | ユナイテッド セラピューティクス コーポレイション | オルトミクソウイルス感染の治療方法 |
| WO2014017915A2 (en) * | 2012-07-27 | 2014-01-30 | Universiteit Utrecht Holding B.V. | Urea and guanidinium derivatives of iminosugars |
-
2014
- 2014-09-15 CA CA2924026A patent/CA2924026C/en active Active
- 2014-09-15 SG SG11201601646YA patent/SG11201601646YA/en unknown
- 2014-09-15 EP EP14844653.7A patent/EP3046558B1/en active Active
- 2014-09-15 JP JP2016542848A patent/JP6456393B2/ja not_active Expired - Fee Related
- 2014-09-15 CN CN201480050939.7A patent/CN105636589B/zh not_active Expired - Fee Related
- 2014-09-15 US US15/022,005 patent/US10144727B2/en active Active
- 2014-09-15 AU AU2014318488A patent/AU2014318488B2/en not_active Ceased
- 2014-09-15 RU RU2016111704A patent/RU2702133C2/ru not_active IP Right Cessation
- 2014-09-15 AP AP2016009125A patent/AP2016009125A0/en unknown
- 2014-09-15 BR BR112016005417A patent/BR112016005417A8/pt active Search and Examination
- 2014-09-15 KR KR1020167010008A patent/KR20160055916A/ko not_active Application Discontinuation
- 2014-09-15 MX MX2016003323A patent/MX2016003323A/es unknown
- 2014-09-15 WO PCT/US2014/055599 patent/WO2015039010A2/en active Application Filing
- 2014-09-15 CR CR20160178A patent/CR20160178A/es unknown
-
2016
- 2016-03-06 IL IL244446A patent/IL244446A0/en active IP Right Grant
- 2016-03-10 PH PH12016500465A patent/PH12016500465A1/en unknown
- 2016-03-14 CL CL2016000597A patent/CL2016000597A1/es unknown
- 2016-09-01 HK HK16110378.3A patent/HK1222129A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112016005417A8 (pt) | 2020-02-18 |
| WO2015039010A2 (en) | 2015-03-19 |
| CR20160178A (es) | 2016-08-08 |
| AU2014318488B2 (en) | 2019-03-07 |
| CA2924026C (en) | 2021-12-28 |
| CL2016000597A1 (es) | 2017-02-24 |
| HK1222129A1 (zh) | 2017-06-23 |
| CN105636589A (zh) | 2016-06-01 |
| IL244446A0 (en) | 2016-04-21 |
| EP3046558A4 (en) | 2017-06-07 |
| EP3046558B1 (en) | 2019-08-14 |
| KR20160055916A (ko) | 2016-05-18 |
| JP6456393B2 (ja) | 2019-01-23 |
| PH12016500465B1 (en) | 2016-05-16 |
| MX2016003323A (es) | 2016-08-12 |
| US10144727B2 (en) | 2018-12-04 |
| RU2702133C2 (ru) | 2019-10-04 |
| JP2016530332A (ja) | 2016-09-29 |
| CA2924026A1 (en) | 2015-03-19 |
| AU2014318488A2 (en) | 2016-04-28 |
| US20160221993A1 (en) | 2016-08-04 |
| WO2015039010A3 (en) | 2015-05-07 |
| PH12016500465A1 (en) | 2016-05-16 |
| AP2016009125A0 (en) | 2016-04-30 |
| RU2016111704A3 (ru) | 2018-06-09 |
| RU2016111704A (ru) | 2017-10-23 |
| CN105636589B (zh) | 2019-07-23 |
| EP3046558A2 (en) | 2016-07-27 |
| AU2014318488A1 (en) | 2016-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1255037A1 (zh) | 製備烟酰胺核苷和其衍生物的方法 | |
| GB2535360B (en) | Methods of preparing polyhemiaminals and polyhexahydrotriazines | |
| HK1217428A1 (zh) | 取代的苯並噁唑及其使用方法 | |
| IL241512A0 (en) | Pharmaceutical preparations containing glycosidase inhibitors and their preparation | |
| IL286759A (en) | Therapeutic methods and preparations | |
| EP3065875A4 (en) | Bioprinter and methods of using same | |
| HK1221611A1 (zh) | 維持和改善肌肉功能的方法 | |
| HK1212977A1 (zh) | 苯達莫司汀衍生物及其使用方法 | |
| HK1222129A1 (zh) | 脱氧野尻霉素衍生物及其使用方法 | |
| EP2999474A4 (en) | THERAPEUTIC AND METHOD OF USE | |
| GB201320723D0 (en) | Composition and methods of treatment | |
| EP2964235A4 (en) | ANTIMICROBIAL-ANTIBIOFILM COMPOSITIONS AND METHODS OF USE | |
| HK1209324A1 (en) | Nanozymes, methods of making nanozymes, and methods of using nanozymes | |
| IL244268A0 (en) | Heterocyclic compounds and methods of use | |
| IL244084A0 (en) | New derivatives of onzialamycin and methods for their synthesis | |
| PL3019477T3 (pl) | Związki heterocykliczne i sposoby ich stosowania | |
| HK1224307A1 (zh) | 原毒素- 變體及其使用方法 | |
| IL245272B (en) | pif-transfected cells and methods of use | |
| IL240695A0 (en) | nme inhibitors and methods of using nme inhibitors | |
| HUE041663T2 (hu) | Myxopyronin és származékai elõállítása | |
| GB201319255D0 (en) | Therapeutic compositions and methods | |
| GB201322508D0 (en) | Dental frameworks and related methods | |
| AU2013902711A0 (en) | Compounds and methods of their use - IV | |
| GB201310349D0 (en) | Composition and method of use thereof | |
| GB201301928D0 (en) | Composition and method of use thereof |